Stem Cell Transplantation |
1 Dept. of Hematology, University Hospital, Basel, Switzerland
2 Service dHematologie, Hopitaux Universitaires de Genève, Geneva, Switzerland
3 Dept. of Childhood Hematology and Oncology, Wroclaw Medical University, Wroclaw, Poland
4 Dept. de Hematologie, Hotel Dieu, Nantes, France
5 Dept. of Haematology and Stem Cell Transplant, St. Laszlo Hospital, Budapest, Hungary
6 Bone Marrow Transplantation Centre, University Hospital Eppendorf, Hamburg, Germany
7 Dept. of Hematology, University Hospital, Lund, Sweden
8 Dept. of Hematology, Addenbrookes Hospital, Cambridge, United Kingdom
9 Dept. of Hematology, Faculty of Medicine, Ankara University, Ankara, Turkey
10 Instituto di Ematologia, Universita Cattolica S. Cuore, Rome, Italy
11 Service de Pediatrie Hematologie-Oncologie, Hopital de Hautepierre, Strasbourg, France
12 Service dHematologie, Greffe, Hospital Saint Louis, Paris, France
Correspondence: André Tichelli, Hematology, University Hospital, CH 4031-Basel, Switzerland. E-mail:tichelli{at}datacomm.ch
Background: Long-term outcome after hematopoietic stem cell transplantation including late transplant-related events is of increasing interest. The aim of this study was to evaluate the incidence of cardiovascular events after allogeneic HSCT and to search for their risk factors.
Design and Methods: This is a retrospective mutlicenter European Group of Blood and Marrow Transplantation (EBMT) analysis, including 548 long-term survivors treated in ten EBMT transplant centers, who underwent hematopoietic stem cell transplantation between 1990 and 1995 and survived
1 year after the transplant. All arterial events occurring after hematopoietic stem cell transplantation (cerebral, coronary, peripheral) were reported.
Results: Twenty (3.6%) out of 548 patients had a cardiovascular event in at least one arterial territory. The median age at occurence of cardiovascular events was 54 years (range, 41–70). The cumulative incidence of a first arterial event 15 years after hematopoietic stem cell transplantation was 6% (95% CI, 3%–10%). The cumulative incidence for patients with a high global cardiovascular risk score, defined as having
50% of the risk factors (arterial hypertension, diabetes, dys-lipidemia, increased body-mass index, physical inactivity, smoking) was 17%, as compared to 4% in those with a low risk score. In multivariate analysis age older than 30 years at last follow-up, and a high global cardiovascular risk score were associated with, respectively, 6.4-fold and 9.8-fold increases in the risk of an arterial event.
Conclusions: Long-term survivors after allogeneic hematopoietic stem cell transplantation are likely to have an increased risk of premature cardiovascular accidents.
Key words: stem cell transplantation, cardiovascular, late effects, long-term survivors.
Related Article
Haematologica 2008 93: 1132-1136.
This article has been cited by other articles:
![]() |
S. H. Armenian and S. Bhatia Cardiovascular disease after hematopoietic cell transplantation - lessons learned Haematologica, August 1, 2008; 93(8): 1132 - 1136. [Full Text] [PDF] |
||||
![]() |
A. Tichelli, A. Rovo, and A. Gratwohl Late Pulmonary, Cardiovascular, and Renal Complications after Hematopoietic Stem Cell Transplantation and Recommended Screening Practices Hematology, January 1, 2008; 2008(1): 125 - 133. [Abstract] [Full Text] [PDF] |
||||